Australian Government added Erythema Multiforme on its COVID-19 Vaccine Claims Scheme on April 3, 2023
by Dr. William Makis MD
November 13, 2023
Papers Reviewed:
- 2023 Jun (Murata et al) – Erythema Multiforme Induced by Zonisamide and Triggered by the First Dose of COVID-19 Vaccine (Pfizer-BioNTech)
- 2023 Apr (Yousefian et al) – Occurrence of erythema multiforme following COVID-19 vaccination: a review
- 2023 Feb (Karatas et al) – Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
- 2022 Nov (Fadul et al) – Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature review
- 2022 Apr (Castillo et al) – Erythema multiforme after the third dose of mRNA-1273 (behind paywall)
- 2022 Mar (Petruzzi et al) – Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases
- 2021 Nov (Burlando et al) – Cutaneous reactions to COVID-19 vaccine at the dermatology primary care
- 2021 Oct (Kim et al) – Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)
- 2021 Oct (Wunderlich et al) – Erythema exsudativum multiforme infolge einer COVID-19-Impfung (BNT162b2)
- 2021 Oct (Saibene et al) – Erythema Multiforme Major following SARS-CoV-2 vaccine
- 2021 Oct (Majenka et al) – Multiforme Erytheme nach COVID-19-mRNA-Impfung
- 2021 Sep (Bonino et al) – Atypical erythema multiforme related to BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine
- 2021 Sep (Borg et al) – Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme
- 2021 Sep (Scharf et al) – Nevocentric erythema multiforme after SARS‐COV‐2 vaccine
